EPTRI actively participates in public consultations on topics, policies and actions giving its contribution to the progress of the paediatric eco-system from a regulatory, ethical and scientific point of view.
Over the years, we have contributed to the following public consultations:
European Commission (EC)
- European Commission (EC): Initiative on the European Health Data Space (EHDS)
- European Commission (EC): Digital health data and services – the European health data space
- European Commission (EC): Pharmaceuticals – safe and affordable medicines (new EU strategy)
- The Biotech Act
- Revision of the Medical Device and In vitro Diagnostic Medical Device Regulations: Official Regulation and EPTRI Position Note
EMA
- European Medicines Agency (EMA): Revision of Regulation (EC) No 141/2000 (the Orphan Regulation) and Regulation (EC) No 1901/2006 (the Paediatric Regulation) (ITA) / Revision of Regulation (EC) No 141/2000 (the Orphan Regulation) and Regulation (EC) No 1901/2006 (the Paediatric Regulation) (ENG)
- European Medicines Agency (EMA): European Medicines Agencies Network Strategy to 2025
EU4Health
EOSC
- European Open Science Cloud (EOSC): EOSC multi-annual roadmap for 2023-24
Horizon Europe